Biotech Stock

Eli Lilly and Nimbus enter into a collaboration to develop therapeutics for metabolic diseases. The two companies will collaborate on the development of novel targeted therapies designed to activate a specific isoform of AMPK (AMP-activated protein kinase) for the potential treatment of metabolic diseases. AMPK is a heterotrimeric complex consisting…

Ten years ago, Jennifer Doudna and her colleagues published the results of a test-tube experiment on bacterial genes in the journal “Science”. This paper was the beginning of an adventurous journey that led to the development of CRISPR technology. In the past decade, CRISPR has become one of the most…

Solving Sleep Disorders The US Food and Drug Administration (FDA) approved Dublin-based Jazz Pharmaceuticals’ Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of idiopathic hypersomnia in adults. Idiopathic hypersomnia is a debilitating neurological sleep disorder characterized by chronic excessive daytime sleepiness, explained Pharma Times. According to…

Answers for Cancer Salarius Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focusing on the development of drugs targeting rare, orphan cancers and cancers with a high unmet need, has added Fox Chase Cancer Center Center in Philadelphia to its ongoing trial of seclidemstat as a treatment for Ewing Sarcoma and…

Minimizing Side Effects Northwest Biotherapeutics, Inc., a Bethesda, Maryland-based clinical stage biotechnology company, focuses on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments and without the side effects of chemotherapy drugs. …

By: Don Hauka The COVID-19 pandemic might be on the downturn, but it will inevitably be followed by new viral variants along with other viruses and pathogens that are difficult to treat Appili Therapeutics is at the forefront of the fight against infectious diseases with a mission to find solutions…

Kidneys and Cash As long as insiders follow disclosure rules, it is not a problem for company leaders, such as directors of the board, to buy and sell stock in the company. At Ardelyx Inc., a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with…

Climbing High Based in Research Triangle Park, North Carolina, BioCryst Pharmaceuticals, Inc. uses crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases and viral infections. …

Surging Stock Early in 2021 shares of GeoVax Labs Inc. …